We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 2022V
InnovaDerma PLC
05 August 2020
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Group")
Directorate Changes
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, today announces that Kieran Callan has stepped down as Chief Executive Officer and as a Director of the Group with immediate effect, by mutual agreement with the Board. Kieran will continue to be available until 31 August 2020 for any handover and to assist the Board in any relevant matters.
The Group has commenced a formal process for the identification and appointment of a new CEO and will provide updates, as appropriate, in due course. In the meantime, Joe Bayer will serve as Interim CEO as well as Executive Chairman.
In addition, InnovaDerma announces that Warren Dockary, currently Group Financial Controller has been appointed as Chief Financial Officer and will report to the Board. Warren is a Chartered Accountant and has been with the business since November 2018. He is a graduate from Massey University in New Zealand and has held senior finance roles in the consumer products and logistics industries.
On behalf of the Board, Executive Chairman and Interim CEO, Joe Bayer said :
"The Board and I would like to thank Kieran for his contribution and strategic insight over the past three years, first as a Non-executive Director then as a CEO when he was appointed in 2018. InnovaDerma is a strong business with a clear strategy, underpinned by a multi-channel approach with ecommerce being the most important factor for future growth. We have agreed that now is the right time for a change of leadership in the Group to implement that strategy and maximise the opportunities that lie ahead.
"We are pleased to have appointed Warren to the role of Chief Financial Officer, and it is particularly pleasing to make this very well-deserved promotion from within the business. Warren has deep knowledge of the business and his appointment strengthens our senior management team."
Kieran Callan, outgoing CEO, said:
"It is a privilege to have worked at InnovaDerma and I leave behind an immensely talented team and a business which is resilient and delivering upon its strategic aims. We have developed our customer-centric and digital-led strategy that will guide the future of the business over the coming years and I feel it is the right time to step down and seek new challenges elsewhere. The Company is strongly positioned and I look forward to see it going from strength to strength."
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma Joe Bayer +61 417 870 743 finnCap Ltd Geoff Nash/Kate Bannatyne +44 (0)207 220 0500 Alice Lane/Manasa Patil - Corporate www.finncap.com Broking --------------------------- TB Cardew Shan Shan Willenbrock/Tom Allison + 44 (0)20 7930 0777 Olivia Rosser innovaDerma@tbcardew.com ---------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOASSFSAIESSEFA
(END) Dow Jones Newswires
August 05, 2020 04:15 ET (08:15 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions